Open AccessEuglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis
Author(s) -
Siddhartha Dutta,
Tarun Kumar,
Surjit Singh,
Sneha Ambwani,
Jaykaran Charan,
Shoban Babu Varthya
Publication year - 2022
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_644_21
Subject(s) - medicine , diabetic ketoacidosis , canagliflozin , metformin , incidence (geometry) , concomitant , diabetes mellitus , clinical trial , pediatrics , type 2 diabetes , insulin , endocrinology , physics , optics
Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) rarely cause euglycemic diabetic ketoacidosis (euDKA) in diabetic patients. The aim was to identify demographic, clinical, and predisposing factors for euDKA from published case reports.